Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Carrier Global
CARR
$57.6B
| $166M | 0.07% |
3,408,891
+69,296
| +2% | +$3.1M |
|
277
American Electric Power
AEP
$72.7B
| $165M | 0.07% |
1,952,468
+320,073
| +20% | +$27.6M |
|
278
Zebra Technologies
ZBRA
$12.6B
| $164M | 0.07% |
310,249
-22,058
| -7% | -$11M |
|
279
Copart
CPRT
$27.6B
| $164M | 0.07% |
4,976,324
+611,308
| +14% | +$19M |
|
280
Edison International
EIX
$30.3B
| $163M | 0.07% |
2,819,573
-380,923
| -12% | -$22.2M |
|
281
Capital One
COF
$127B
| $159M | 0.07% |
1,027,518
-132
| -0% | -$19.9K |
|
282
Fate Therapeutics
FATE
$283M
| $158M | 0.07% |
1,825,984
-74,648
| -4% | -$6.02M |
|
283
Insulet
PODD
$11.4B
| $158M | 0.07% |
576,697
-73,051
| -11% | -$19.9M |
|
284
Sempra
SRE
$59.7B
| $158M | 0.07% |
2,381,058
-108,272
| -4% | -$7.41M |
|
285
Saia
SAIA
$11.2B
| $157M | 0.07% |
751,540
-30,587
| -4% | -$6.94M |
|
286
Chevron
CVX
$378B
| $155M | 0.07% |
1,480,084
+557,625
| +60% | +$58.9M |
|
287
Nutrien
NTR
$32.4B
| $155M | 0.07% |
2,553,672
-586,474
| -19% | -$34.7M |
|
288
Sea Limited
SE
$63.9B
| $155M | 0.07% |
563,826
+310,715
| +123% | +$78.9M |
|
289
Vanguard S&P 500 ETF
VOO
$968B
| $154M | 0.07% |
391,277
+25,733
| +7% | +$9.88M |
|
290
Royalty Pharma
RPRX
$26B
| $154M | 0.07% |
3,745,414
+2,505,360
| +202% | +$107M |
|
291
First Horizon
FHN
$12.1B
| $153M | 0.07% |
8,833,167
-474,743
| -5% | -$8.62M |
|
292
argenx
ARGX
$55.6B
| $150M | 0.06% |
498,060
+43,772
| +10% | +$12.4M |
|
293
PTC Therapeutics
PTCT
$6.29B
| $148M | 0.06% |
3,503,914
+434,774
| +14% | +$18.6M |
|
294
Jazz Pharmaceuticals
JAZZ
$16B
| $148M | 0.06% |
830,408
+7,007
| +0.9% | +$1.21M |
|
295
Icon
ICLR
$13B
| $147M | 0.06% |
711,598
+202,659
| +40% | +$43.7M |
|
296
BWX Technologies
BWXT
$16.2B
| $145M | 0.06% |
2,487,033
-49,789
| -2% | -$3.2M |
|
297
Azenta
AZTA
$1.27B
| $143M | 0.06% |
1,505,109
-2,312
| -0.2% | -$224K |
|
298
CrowdStrike
CRWD
$183B
| $143M | 0.06% |
2,270,648
+48,084
| +2% | +$2.59M |
|
299
Alexandria Real Estate Equities
ARE
$8.96B
| $142M | 0.06% |
779,963
+224,738
| +40% | +$40.2M |
|
300
Applied Materials
AMAT
$410B
| $141M | 0.06% |
989,160
-982,574
| -50% | -$132M |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.